CN104761522B - 光学纯的苄基‑4‑氯苯基的c‑糖苷衍生物 - Google Patents

光学纯的苄基‑4‑氯苯基的c‑糖苷衍生物 Download PDF

Info

Publication number
CN104761522B
CN104761522B CN201410004395.2A CN201410004395A CN104761522B CN 104761522 B CN104761522 B CN 104761522B CN 201410004395 A CN201410004395 A CN 201410004395A CN 104761522 B CN104761522 B CN 104761522B
Authority
CN
China
Prior art keywords
formula
compound
preparation
benzyl
diabetes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201410004395.2A
Other languages
English (en)
Chinese (zh)
Other versions
CN104761522A (zh
Inventor
吴永谦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jilin Huisheng Biopharmaceutical Co ltd
Beijing Huizhiheng Biological Technology Co Ltd
Original Assignee
Xuanzhu Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xuanzhu Pharma Co Ltd filed Critical Xuanzhu Pharma Co Ltd
Priority to CN201410004395.2A priority Critical patent/CN104761522B/zh
Priority to CN201610635305.9A priority patent/CN106349201B/zh
Priority to JP2014043695A priority patent/JP6008892B2/ja
Priority to KR1020140037632A priority patent/KR101837488B1/ko
Publication of CN104761522A publication Critical patent/CN104761522A/zh
Priority to HK15108213.7A priority patent/HK1207626B/xx
Application granted granted Critical
Publication of CN104761522B publication Critical patent/CN104761522B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN201410004395.2A 2014-01-03 2014-01-03 光学纯的苄基‑4‑氯苯基的c‑糖苷衍生物 Active CN104761522B (zh)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CN201410004395.2A CN104761522B (zh) 2014-01-03 2014-01-03 光学纯的苄基‑4‑氯苯基的c‑糖苷衍生物
CN201610635305.9A CN106349201B (zh) 2014-01-03 2014-01-03 光学纯的苄基-4-氯苯基的c-糖苷衍生物
JP2014043695A JP6008892B2 (ja) 2014-01-03 2014-03-06 光学的に純粋なベンジル‐４−クロロフェニル‐ｃ‐グルコシド誘導体
KR1020140037632A KR101837488B1 (ko) 2014-01-03 2014-03-31 광학적으로 순수한 벤질-4-클로로페닐-c-글루코사이드 유도체
HK15108213.7A HK1207626B (en) 2015-08-25 Optically pure benzyl-4-chlorophenyl c-glucoside derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410004395.2A CN104761522B (zh) 2014-01-03 2014-01-03 光学纯的苄基‑4‑氯苯基的c‑糖苷衍生物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201610635305.9A Division CN106349201B (zh) 2014-01-03 2014-01-03 光学纯的苄基-4-氯苯基的c-糖苷衍生物

Publications (2)

Publication Number Publication Date
CN104761522A CN104761522A (zh) 2015-07-08
CN104761522B true CN104761522B (zh) 2017-02-15

Family

ID=53643666

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201410004395.2A Active CN104761522B (zh) 2014-01-03 2014-01-03 光学纯的苄基‑4‑氯苯基的c‑糖苷衍生物
CN201610635305.9A Active CN106349201B (zh) 2014-01-03 2014-01-03 光学纯的苄基-4-氯苯基的c-糖苷衍生物

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201610635305.9A Active CN106349201B (zh) 2014-01-03 2014-01-03 光学纯的苄基-4-氯苯基的c-糖苷衍生物

Country Status (3)

Country Link
JP (1) JP6008892B2 (enrdf_load_stackoverflow)
KR (1) KR101837488B1 (enrdf_load_stackoverflow)
CN (2) CN104761522B (enrdf_load_stackoverflow)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105153137A (zh) * 2015-09-17 2015-12-16 上海应用技术学院 一种艾格列净的制备方法
RU2739024C2 (ru) * 2016-01-04 2020-12-21 Че Иль Фармасьютикал Ко., Лтд. С-гликозидные производные, содержащие конденсированное фенильное кольцо, или их фармацевтически приемлемые соли, способ получения таковых и фармацевтическая композиция, содержащая таковые
CN109476624B (zh) * 2016-05-28 2021-07-09 吉林惠升生物制药有限公司 钠-葡萄糖协同转运蛋白2抑制剂的晶型
CN108285439B (zh) * 2017-01-09 2023-05-02 江苏天士力帝益药业有限公司 一种碳糖苷类钠葡萄糖转运蛋白体2抑制剂
WO2019185026A1 (zh) * 2018-03-30 2019-10-03 南京明德新药研发有限公司 作为SGLTs抑制剂的葡糖苷类衍生物及其应用
CN110551088B (zh) * 2018-06-01 2022-10-21 北京惠之衡生物科技有限公司 氘修饰的苄基-4-氯苯基的c-糖苷衍生物
CN112047915B (zh) * 2019-06-05 2023-02-17 北京惠之衡生物科技有限公司 C-糖苷类衍生物新的制备工艺
CN110683998A (zh) * 2019-11-20 2020-01-14 杭州华东医药集团浙江华义制药有限公司 一种恩格列净中间体的制备方法
CN113248464B (zh) * 2021-05-31 2021-10-26 北京惠之衡生物科技有限公司 一种c-糖苷类衍生物的合成方法
CN113045525B (zh) * 2021-05-31 2021-09-17 北京惠之衡生物科技有限公司 一种c-糖苷类衍生物的制备方法及其制剂
CN113336733B (zh) * 2021-05-31 2022-02-18 北京惠之衡生物科技有限公司 一种sglt-2抑制剂的l-脯氨酸共结晶体的制备方法
CN113248554A (zh) * 2021-06-25 2021-08-13 北京惠之衡生物科技有限公司 一种c-糖苷类衍生物的杂质的合成方法
CN113372315B (zh) * 2021-08-12 2021-10-29 北京惠之衡生物科技有限公司 一种c-糖苷类衍生物的杂质的合成方法
CN115073271A (zh) * 2022-06-08 2022-09-20 苏州敬业医药化工有限公司 一种4’-(5-溴-2-氯苄基)苯酚的制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1653075A (zh) * 2002-05-20 2005-08-10 百时美施贵宝公司 C－芳基葡糖苷sglt2抑制剂和方法
WO2013000275A1 (zh) * 2011-06-25 2013-01-03 山东轩竹医药科技有限公司 C-糖苷衍生物
CN103030617A (zh) * 2004-03-16 2013-04-10 贝林格尔.英格海姆国际有限公司 吡喃葡萄糖基取代的苯基衍生物、含该化合物的药物、其用途及其制造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1581543A4 (en) * 2003-01-03 2008-03-19 Bristol Myers Squibb Co METHODS FOR PRODUCING SGLT2 GLYCOSIS C-ARYL INHIBITORS
US7772191B2 (en) * 2005-05-10 2010-08-10 Boehringer Ingelheim International Gmbh Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
PL2548871T3 (pl) * 2010-03-18 2017-12-29 Daiichi Sankyo Company, Limited Pochodne imidazolu podstawionego cykloalkilem
WO2012025857A1 (en) * 2010-08-23 2012-03-01 Hetero Research Foundation Cycloalkyl methoxybenzyl phenyl pyran derivatives as sodium dependent glucose co transporter (sglt2) inhibitors

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1653075A (zh) * 2002-05-20 2005-08-10 百时美施贵宝公司 C－芳基葡糖苷sglt2抑制剂和方法
CN103030617A (zh) * 2004-03-16 2013-04-10 贝林格尔.英格海姆国际有限公司 吡喃葡萄糖基取代的苯基衍生物、含该化合物的药物、其用途及其制造方法
WO2013000275A1 (zh) * 2011-06-25 2013-01-03 山东轩竹医药科技有限公司 C-糖苷衍生物

Also Published As

Publication number Publication date
JP2015129106A (ja) 2015-07-16
KR20150081220A (ko) 2015-07-13
CN104761522A (zh) 2015-07-08
KR101837488B1 (ko) 2018-03-12
CN106349201B (zh) 2018-09-18
CN106349201A (zh) 2017-01-25
JP6008892B2 (ja) 2016-10-19
HK1207626A1 (zh) 2016-02-05

Similar Documents

Publication Publication Date Title
CN104761522B (zh) 光学纯的苄基‑4‑氯苯基的c‑糖苷衍生物
TWI309980B (en) C-glycoside derivatives or salts thereof
CN102827122B (zh) 糖苷衍生物
TWI594756B (zh) 糖苷衍生物及其用途
EP2725031B1 (en) C-glycoside derivatives
CN103748090B (zh) 糖苷衍生物及其用于治疗糖尿病的用途
EP2891654B1 (en) Optically pure benzyl-4-chlorophenyl-C-glucoside derivatives as SGLT inhibitors (diabetes mellitus)
NZ536681A (en) Azulene derivatives and use in producing a Na-glucose cotransporter inhibitor or an antidiabetic agent
EA021983B1 (ru) Производные диоксабицикло[3.2.1]октан-2,3,4-триола
WO2011091710A1 (zh) 苯基c-葡萄糖苷衍生物、其制备方法和用途
EP2755722A2 (en) Novel sglt inhibitors
US9914688B2 (en) Optically pure benzyl-4-chlorophenyl-C-glucoside derivative
WO2004099230A1 (en) Monosaccharide compounds
JP2021512066A (ja) グルコピラノシル誘導体及びその使用
RU2739024C2 (ru) С-гликозидные производные, содержащие конденсированное фенильное кольцо, или их фармацевтически приемлемые соли, способ получения таковых и фармацевтическая композиция, содержащая таковые
US8871726B2 (en) C-aryl glucoside derivative, preparation method therefor, and use thereof
CN108285439A (zh) 一种碳糖苷类钠葡萄糖转运蛋白体2抑制剂
HK1207626B (en) Optically pure benzyl-4-chlorophenyl c-glucoside derivative
EP4119550A1 (en) Aryl glucoside derivative and use thereof in drug
US20230365610A1 (en) Aryl Glucoside Derivative
HK1259905B (zh) 具有稠合苯环的c-葡糖苷衍生物或其药物学可接受的盐、其制备方法以及包含其的药物组合物
CN110551088A (zh) 氘修饰的苄基-4-氯苯基的c-糖苷衍生物
HK40012941A (en) Macrocyclic broad spectrum antibiotics
HK1191653B (en) C-glycoside derivatives

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
EXSB Decision made by sipo to initiate substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1207626

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1207626

Country of ref document: HK

TR01 Transfer of patent right

Effective date of registration: 20171226

Address after: Room 4905, exhibition square, 1 Hong Kong Bay Road, Wan Chai, Hongkong, China

Co-patentee after: XUANZHU PHARMA Co.,Ltd.

Patentee after: SIHUAN PHARMACEUTICAL HOLDINGS Group Ltd.

Address before: Tianchen Avenue, Ji'nan hi tech Development Zone of Shandong Province, No. 2518 250101

Patentee before: XUANZHU PHARMA Co.,Ltd.

TR01 Transfer of patent right
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20190715

Address after: 250101 No. 2518 Tianchen Road, Jinan High-tech Zone, Shandong Province

Patentee after: XUANZHU PHARMA Co.,Ltd.

Address before: Room 4905, Office Building, Exhibition Plaza, 1 Harbour Road, Wanchai, Hong Kong, China

Co-patentee before: XUANZHU PHARMA Co.,Ltd.

Patentee before: SIHUAN PHARMACEUTICAL HOLDINGS Group Ltd.

TR01 Transfer of patent right

Effective date of registration: 20191018

Address after: Room 510, building 2, No. 88, Kechuang 6th Street, Beijing Economic and Technological Development Zone, Beijing 100176

Patentee after: Xuanzhu (Beijing) Pharmaceutical Technology Co.,Ltd.

Address before: High tech Zone Tianchen road Ji'nan City, Shandong province 250101 No. 2518

Patentee before: XUANZHU PHARMA Co.,Ltd.

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20200925

Address after: 135000 No. 666, Kangmei Avenue, Meihekou City, Tonghua City, Jilin Province

Patentee after: Jilin Huisheng biopharmaceutical Co.,Ltd.

Patentee after: Beijing huizhiheng Biotechnology Co.,Ltd.

Address before: Room 510, building 2, No. 88, Kechuang 6th Street, Beijing Economic and Technological Development Zone, Beijing 100176

Patentee before: Xuanzhu (Beijing) Pharmaceutical Technology Co.,Ltd.

TR01 Transfer of patent right
CP03 Change of name, title or address

Address after: 135007 No. 666, Kangmei Avenue, Meihekou City, Tonghua City, Jilin Province

Patentee after: Jilin Huisheng Biopharmaceutical Co.,Ltd.

Patentee after: Beijing huizhiheng Biotechnology Co.,Ltd.

Address before: NO.666 Kangmei Avenue, Meihekou City, Tonghua City, Jilin Province

Patentee before: Jilin Huisheng biopharmaceutical Co.,Ltd.

Patentee before: Beijing huizhiheng Biotechnology Co.,Ltd.

CP03 Change of name, title or address
PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: Optically pure C-glycoside derivatives of benzyl-4-chlorophenyl

Effective date of registration: 20231013

Granted publication date: 20170215

Pledgee: Jilin Bank Co.,Ltd. Tonghua Meihekou Branch

Pledgor: Jilin Huisheng Biopharmaceutical Co.,Ltd.

Registration number: Y2023220000102

PE01 Entry into force of the registration of the contract for pledge of patent right
PC01 Cancellation of the registration of the contract for pledge of patent right
PC01 Cancellation of the registration of the contract for pledge of patent right

Granted publication date: 20170215

Pledgee: Jilin Bank Co.,Ltd. Tonghua Meihekou Branch

Pledgor: Jilin Huisheng Biopharmaceutical Co.,Ltd.

Registration number: Y2023220000102

PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: Optically pure C-glycoside derivatives of benzyl-4-chlorophenyl

Granted publication date: 20170215

Pledgee: Industrial and Commercial Bank of China Limited Meihekou Branch

Pledgor: Jilin Huisheng Biopharmaceutical Co.,Ltd.

Registration number: Y2024220000070